Increased Moxifloxacin Utilization Associated with an Unrestricted Addition to a Drug Reimbursement Formulary: A Population-Based Analysis
OBJECTIVES:To determine whether utilization of moxifloxacin, a broad-spectrum fluoroquinolone antibiotic, has changed since its addition to the British Columbia provincial formulary in 2009 and to determine whether utilization was guideline concordant.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2014/243014 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832553935973384192 |
|---|---|
| author | Alissa Jade Wright Fawziah Marra Mei Chong Catharine Chambers William R Bowie David M Patrick |
| author_facet | Alissa Jade Wright Fawziah Marra Mei Chong Catharine Chambers William R Bowie David M Patrick |
| author_sort | Alissa Jade Wright |
| collection | DOAJ |
| description | OBJECTIVES:To determine whether utilization of moxifloxacin, a broad-spectrum fluoroquinolone antibiotic, has changed since its addition to the British Columbia provincial formulary in 2009 and to determine whether utilization was guideline concordant. |
| format | Article |
| id | doaj-art-3804282501354d73aa0765bb3f04e7f2 |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-3804282501354d73aa0765bb3f04e7f22025-02-03T05:52:49ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322014-01-01251273110.1155/2014/243014Increased Moxifloxacin Utilization Associated with an Unrestricted Addition to a Drug Reimbursement Formulary: A Population-Based AnalysisAlissa Jade Wright0Fawziah Marra1Mei Chong2Catharine Chambers3William R Bowie4David M Patrick5Department of Medicine, Division of Infectious Disease, University of British Columbia, Vancouver General Hospital, CanadaDepartment of Medicine, Division of Infectious Disease, University of British Columbia, Vancouver General Hospital, CanadaBritish Columbia Centre for Disease Control, University of British Columbia, Vancouver, British Columbia, CanadaBritish Columbia Centre for Disease Control, University of British Columbia, Vancouver, British Columbia, CanadaDepartment of Medicine, Division of Infectious Disease, University of British Columbia, Vancouver General Hospital, CanadaBritish Columbia Centre for Disease Control, University of British Columbia, Vancouver, British Columbia, CanadaOBJECTIVES:To determine whether utilization of moxifloxacin, a broad-spectrum fluoroquinolone antibiotic, has changed since its addition to the British Columbia provincial formulary in 2009 and to determine whether utilization was guideline concordant.http://dx.doi.org/10.1155/2014/243014 |
| spellingShingle | Alissa Jade Wright Fawziah Marra Mei Chong Catharine Chambers William R Bowie David M Patrick Increased Moxifloxacin Utilization Associated with an Unrestricted Addition to a Drug Reimbursement Formulary: A Population-Based Analysis Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Increased Moxifloxacin Utilization Associated with an Unrestricted Addition to a Drug Reimbursement Formulary: A Population-Based Analysis |
| title_full | Increased Moxifloxacin Utilization Associated with an Unrestricted Addition to a Drug Reimbursement Formulary: A Population-Based Analysis |
| title_fullStr | Increased Moxifloxacin Utilization Associated with an Unrestricted Addition to a Drug Reimbursement Formulary: A Population-Based Analysis |
| title_full_unstemmed | Increased Moxifloxacin Utilization Associated with an Unrestricted Addition to a Drug Reimbursement Formulary: A Population-Based Analysis |
| title_short | Increased Moxifloxacin Utilization Associated with an Unrestricted Addition to a Drug Reimbursement Formulary: A Population-Based Analysis |
| title_sort | increased moxifloxacin utilization associated with an unrestricted addition to a drug reimbursement formulary a population based analysis |
| url | http://dx.doi.org/10.1155/2014/243014 |
| work_keys_str_mv | AT alissajadewright increasedmoxifloxacinutilizationassociatedwithanunrestrictedadditiontoadrugreimbursementformularyapopulationbasedanalysis AT fawziahmarra increasedmoxifloxacinutilizationassociatedwithanunrestrictedadditiontoadrugreimbursementformularyapopulationbasedanalysis AT meichong increasedmoxifloxacinutilizationassociatedwithanunrestrictedadditiontoadrugreimbursementformularyapopulationbasedanalysis AT catharinechambers increasedmoxifloxacinutilizationassociatedwithanunrestrictedadditiontoadrugreimbursementformularyapopulationbasedanalysis AT williamrbowie increasedmoxifloxacinutilizationassociatedwithanunrestrictedadditiontoadrugreimbursementformularyapopulationbasedanalysis AT davidmpatrick increasedmoxifloxacinutilizationassociatedwithanunrestrictedadditiontoadrugreimbursementformularyapopulationbasedanalysis |